© 2019 The Sonder Group

 The fact that woman continue to be under represented in key areas of the work place is nothing new. Less than five percent of the Fortune 1000 companies are led by woman. Although woman earn about half the doctorates in science and engineering, they account for less than 25% of the full time professor positions. This leadership gap is compounded by a wage gap where woman are paid less for the same job. In 2012, earnings for women in full-time management, professional, and related occupations were only 72% of men’s....

To Give or not to give, that is the question… But the answer seems obvious when you listen to Adam Grant, Bob Burg and John David Mann. Adam, a Professor of Management at Wharton School, earned a Ph.D. in organizational psychology after attending Harvard. He is an expert in the field of motivation, pro-social giving and collegial behaviors. His new book, Give and Take: A Revolutionary Approach to Success, is gaining a lot of attention. His main premise is that helping others is not a time guzzling chore but rather a powerful motivator...

Well, we are little more than half-way through 2013 and I couldn’t resist giving my business impressions on the year so far, and think about how that affects business growth and hiring. If you pardon the sports analogies, get your head in the game, and let’s figure out the game plan.

The scoreboard: Stocks & IPOs –  Earlier this month, Burrill and company reported good news. Life science stocks were out performing other major indices this year. Life Science companies raised $56.2 billion in cash during the first half of 2013; 60% more...

Cross-training’s not just for the gym anymore, people. PricewatershouseCoopers (PWC) just released “New chemistry: Getting the Biopharmaceutical Talent Formula Right,” their report on the education and skills that will be needed for the pharmaceutical jobs of tomorrow. The takeaway? Learn more than just (!) science.

The PWC report predicts that most pharma companies will be revamping their R&D organization models from a pure science orientation to one that leverages partnerships and alliances. This is no surprise. Pharma’s increas...

Please reload

Categories
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon